Ossio Inc

Based in the US, Ossio Inc is a manufacturer of innovative orthopedic implant technologies, focusing on natural integration within the body to enhance patient recovery without permanent hardware. Ossio Inc specializes in advanced orthopedic solutions. Founded in 2014 in Woburn, US, the company has raised a total of USD 27. 60 mn in funding, with its latest round of USD 27.

60 mn in December 2024 led by Questa Capital Management. The founder, Orahn Preiss-Bloom, has a background in developing medical technologies and has contributed significantly to the company's vision. OSSIO Inc. specializes in developing advanced orthopedic implant technologies, particularly OSSIO fiber®, an innovative implant material designed to securely fixate and fully integrate into the body’s native anatomy without leaving any permanent hardware behind.

OSSIO fiber® is composed of natural minerals found in bones, offering a robust and bio-integrative solution that promotes healing naturally. This technology addresses various orthopedic needs, particularly in procedures such as hammertoe corrections, providing a permanent solution to patients without the complications associated with traditional metal implants. OSSIO's products are primarily targeted towards orthopedic surgeons and healthcare facilities, focusing on markets across North America, Europe, and select regions in Asia, where the demand for advanced bone healing solutions is growing. OSSIO operates on a revenue model that includes direct sales of its flagship products to healthcare providers, including hospitals and surgical centers.

The company’s transactions typically involve bulk orders of its OSSIO fiber® implants and related products, which are priced according to specific clinical needs and procedure types. This direct-to-consumer approach facilitates a streamlined ordering process for surgeons, allowing them to access the implants required for their patients promptly. By focusing on strong relationships with orthopedic specialists and leveraging a high satisfaction rate among users, OSSIO aims to enhance its market presence and drive consistent revenue growth through repeat orders and recommendations. The revenue is generated primarily from sales of OSSIO fiber® implants, as well as its associated products such as compression screws and fixation nails, which serve various orthopedic applications.

In December 2024, Ossio Inc raised USD 27. 6 mn in venture funding led by Questa Capital Management, with participation from Courage Capital Management, MVM Partners, OCV Partners, and Ortho Vision, LLC. The company will utilize the funding to accelerate its business by enhancing sales infrastructure and developing various types of services. OSSIO plans to introduce new products to the market, with specific timelines for release not yet disclosed.

Additionally, the company is targeting expansion into new geographic regions, particularly in Europe and select Asian markets, to increase its footprint by mid-2025.